...
首页> 外文期刊>Cell metabolism >HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis.
【24h】

HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis.

机译:HDL,ABC转运蛋白和胆固醇外流:对动脉粥样硬化的治疗意义。

获取原文
获取原文并翻译 | 示例
           

摘要

High-density lipoprotein (HDL) has been identified as a potential target in the treatment of atherosclerotic vascular disease. The failure of torcetrapib, an inhibitor of cholesteryl ester transfer protein (CETP) that markedly increased HDL levels in a clinical trial, has called into doubt the efficacy of HDL elevation. Recent analysis suggests that failure may have been caused by off-target toxicity and that HDL is functional and promotes regression of atherosclerosis. New studies highlight the central importance of the ATP-binding cassette (ABC) transporters ABCA1 and ABCG1 in reducing macrophage foam cell formation, inflammation, and atherosclerosis. A variety of approaches to increasing HDL may eventually be successful in treating atherosclerosis.
机译:高密度脂蛋白(HDL)已被确定为治疗动脉粥样硬化性血管疾病的潜在靶标。在临床试验中,胆固醇酯转移蛋白(CETP)抑制剂torcetrapib的失败显着提高了HDL水平,这使人们怀疑HDL升高的功效。最近的分析表明,衰竭可能是由脱靶毒性引起的,并且HDL具有功能并促进了动脉粥样硬化的消退。新研究强调了ATP结合盒(ABC)转运蛋白ABCA1和ABCG1在减少巨噬细胞泡沫细胞形成,炎症和动脉粥样硬化中的重要作用。各种增加HDL的方法最终可能会成功治疗动脉粥样硬化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号